Rein Therapeutics
Biotechnology Research • 
12407 N Mo Pac Expy, 390, United States • 11-20 Employees
Company overview
| Headquarters | 12407 N Mo Pac Expy, 390, Austin, Texas 78758, US |
| Phone number | +16179950900 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biopharmaceuticals, Drug Development, Pulmonary, Fibrosis |
| Founded | 2025 |
| Employees | 11-20 |
| Socials |
Key Contacts at Rein Therapeutics
Brian Windsor
President And Chief Executive Officer
Breanne Mackenzie
Director Of Translational Research
Rein Therapeutics Email Formats
Rein Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@aileronrx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@aileronrx.com | 100% |
About Rein Therapeutics
Rein Therapeutics is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class therapies to address significant unmet medical needs in orphan pulmonary and fibrosis indications. Rein's lead product candidate, LTI-03, is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is anticipated to initiate a Phase 2 clinical trial in the first half of 2025 for the treatment of idiopathic pulmonary fibrosis. Rein’s second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions. LTI-01 has received Orphan Drug Designation in the U.S. and E.U. and Fast Track Designation in the U.S. For more information, please visit www.reintx.com or follow us on Twitter at @Rein_Tx.
Rein Therapeutics revenue & valuation
| Annual revenue | $4,000,000 |
| Revenue per employee | $236,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $12,800,000 |
| Total funding | $41,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Rein Therapeutics has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Explore Rein Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Spain
Korea, Republic of
Canada
United KingdomFrequently asked questions
4.8
40,000 users
